Skip to content
Agentic OS
Menu

Intelligence / Healthtech & medtech market map / Clinical and regulatory support services / Market access, reimbursement and health-economic services / Cross-buyer launch support and health-economic evidence services

NicheREVIEWEDResearched 14 Nov 2026 · refreshed weekly

Cross-buyer launch support and health-economic evidence services

Medical-device, diagnostic, digital-health, pharmaceutical and biotechnology vendors buying integrated launch support, health-economic evidence development and cross-functional market-access execution spanning dossiers, pricing and payer engagement.

Market size
—
Not sized yet
Growth
—
CAGR
Attractiveness
80 /100
for B2B sellers
Evidence
not sized
8 sources · no estimate
Level
Niche
Segmented by
Customer type
Buyers
Medical-device, diagnostic, digital-health, pharmaceutical and biotechnology vendors
Buying centre
Market access, health economics, regulatory, evidence and commercial-launch teams
Buying triggers
  • Multi-market launch
  • Complex or novel technology with uncertain reimbursement
  • Payer evidence or value-assessment challenge
  • Need to coordinate dossier, pricing and payer engagement
Pains
  • Multiple workstreams and vendors
  • Inconsistent evidence across dossiers and payer materials
  • Unclear accountability for launch execution
  • Compressed timelines
Scores (1–5)
Pain intensity4
Purchasing power4
Reachability4
Growth4

How this was sized

Not sized yet

No source isolates integrated launch support or health-economic services. Regulatory-affairs outsourcing market figures are broader proxies and cannot be attributed to this niche without an unsupported allocation assumption.

Alongside it in Market access, reimbursement and health-economic services

// Sell into Cross-buyer launch support and health-economic evidence services

AOS finds the biggest accounts in this niche with a reason to talk now, maps their buying centre and prepares the outreach for your approval.